Literature DB >> 25337055

Change in perceived health insurance coverage among people with multiple sclerosis.

Alyssa Pozniak1, Louise Hadden1, William Rhodes1, Sarah Minden1.   

Abstract

BACKGROUND: Previous research suggests that most people with multiple sclerosis (MS) in the United States have health insurance. However, little is known about their coverage or how it differs between public and private insurance. We examined whether the perceived change in health insurance coverage from the previous year differs between individuals with MS who are privately insured compared with those who are publicly insured.
METHODS: We present descriptive statistics and odds ratios (ORs) from a multivariate logistic regression using data from the 2009 wave of the Sonya Slifka Longitudinal Multiple Sclerosis Study.
RESULTS: We found that individuals with Medicare were significantly less likely to perceive worse coverage compared with those with private health insurance (OR = 0.53; P < .01). Individuals aged 55 to 64 years were more likely to perceive worse coverage than those aged 18 to 34 years (OR = 2.5; P < .05), while the odds of perceiving worse coverage were significantly lower for individuals who had been diagnosed more than 15 years previously relative to those diagnosed in the past 2 years (OR = 0.48; P < .05).
CONCLUSIONS: Individuals with MS and other chronic illnesses who can choose between public and private insurance should be aware that there are important differences in perceptions of health insurance coverage between publicly and privately insured individuals.

Entities:  

Year:  2014        PMID: 25337055      PMCID: PMC4204373          DOI: 10.7224/1537-2073.2013-037

Source DB:  PubMed          Journal:  Int J MS Care        ISSN: 1537-2073


  11 in total

Review 1.  Economic evidence in multiple sclerosis: a review.

Authors:  Gisela Kobelt
Journal:  Eur J Health Econ       Date:  2004-10

Review 2.  Cost of multiple sclerosis by level of disability: a review of literature.

Authors:  M B Patwardhan; D B Matchar; G P Samsa; D C McCrory; R G Williams; T T Li
Journal:  Mult Scler       Date:  2005-04       Impact factor: 6.312

3.  Health, disability, and life insurance experiences of working-age persons with multiple sclerosis.

Authors:  L I Iezzoni; L Ngo
Journal:  Mult Scler       Date:  2007-01-29       Impact factor: 6.312

4.  Favorable selection, risk adjustment, and the Medicare Advantage program.

Authors:  Michael A Morrisey; Meredith L Kilgore; David J Becker; Wilson Smith; Elizabeth Delzell
Journal:  Health Serv Res       Date:  2012-10-22       Impact factor: 3.402

5.  Impact of continued biased disenrollment from the Medicare Advantage Program to fee-for-service.

Authors:  Gerald F Riley
Journal:  Medicare Medicaid Res Rev       Date:  2012-01-30

Review 6.  The economics of multiple sclerosis. Distribution of costs and relationship to disease severity.

Authors:  A N Grudzinski; Z Hakim; E R Cox; J L Bootman
Journal:  Pharmacoeconomics       Date:  1999-03       Impact factor: 4.981

7.  The Sonya Slifka Longitudinal Multiple Sclerosis Study: methods and sample characteristics.

Authors:  S L Minden; D Frankel; L Hadden; J Perloffp; K P Srinath; D C Hoaglin
Journal:  Mult Scler       Date:  2006-02       Impact factor: 6.312

8.  All-cause health care utilization and costs associated with newly diagnosed multiple sclerosis in the United States.

Authors:  Carl V Asche; Mendel E Singer; Mehul Jhaveri; Hsingwen Chung; Aaron Miller
Journal:  J Manag Care Pharm       Date:  2010 Nov-Dec

9.  A comprehensive assessment of the cost of multiple sclerosis in the United States.

Authors:  K Whetten-Goldstein; F A Sloan; L B Goldstein; E D Kulas
Journal:  Mult Scler       Date:  1998-10       Impact factor: 6.312

10.  Steps to reduce favorable risk selection in medicare advantage largely succeeded, boding well for health insurance exchanges.

Authors:  Joseph P Newhouse; Mary Price; Jie Huang; J Michael McWilliams; John Hsu
Journal:  Health Aff (Millwood)       Date:  2012-12       Impact factor: 6.301

View more
  2 in total

1.  Health insurance affects the use of disease-modifying therapy in multiple sclerosis.

Authors:  Guoqiao Wang; Ruth Ann Marrie; Amber R Salter; Robert Fox; Stacey S Cofield; Tuula Tyry; Gary R Cutter
Journal:  Neurology       Date:  2016-06-29       Impact factor: 9.910

2.  Assessing Four Quality Indicators for Multiple Sclerosis Management Through Patient-Reported Data.

Authors:  Sarah J Shoemaker; Alyssa Pozniak; Louise Hadden
Journal:  Int J MS Care       Date:  2016 Jul-Aug
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.